This study was designed to determine the expression of BMP-2 and its receptors in epithelial ovarian cancer, benign ovarian tumors, and normal ovarian tissue and to analyze their influence on the five-year survival rate and average survival time of ovarian cancer patients. This evidence concerns the gene BMP2 and ovarian cancer.